Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. SPY
3. ABBV
4. FDX
5. IBM
6. META
7. MU
8. ACN
9. USO
10. NVDA

Go back to Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor
(NASDAQ: PRAX) Delayed: 305.37 +1.98 (0.65%)
Previous Close $303.39    52 Week High $ 
Open $298.50    52 Week Low $ 
Day High $308.01    P/E N/A 
Day Low $296.36    EPS $ 
Volume 509,571